BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29153587)

  • 1. Advancing Research Models and Technologies to Overcome Biological Barriers to Plasmodium vivax Control.
    Armistead JS; Adams JH
    Trends Parasitol; 2018 Feb; 34(2):114-126. PubMed ID: 29153587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium vivax - How hidden reservoirs hinder global malaria elimination.
    Angrisano F; Robinson LJ
    Parasitol Int; 2022 Apr; 87():102526. PubMed ID: 34896312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax vaccine research - we've only just begun.
    Tham WH; Beeson JG; Rayner JC
    Int J Parasitol; 2017 Feb; 47(2-3):111-118. PubMed ID: 27899329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite.
    Mueller I; Galinski MR; Baird JK; Carlton JM; Kochar DK; Alonso PL; del Portillo HA
    Lancet Infect Dis; 2009 Sep; 9(9):555-66. PubMed ID: 19695492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of vaccines for Plasmodium vivax malaria.
    Mueller I; Shakri AR; Chitnis CE
    Vaccine; 2015 Dec; 33(52):7489-95. PubMed ID: 26428453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax Reticulocyte Binding Proteins for invasion into reticulocytes.
    Chan LJ; Dietrich MH; Nguitragool W; Tham WH
    Cell Microbiol; 2020 Jan; 22(1):e13110. PubMed ID: 31469946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Biology of
    Adams JH; Mueller I
    Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 28490540
    [No Abstract]   [Full Text] [Related]  

  • 9. Widespread distribution of Plasmodium vivax malaria in Mauritania on the interface of the Maghreb and West Africa.
    Ba H; Duffy CW; Ahouidi AD; Deh YB; Diallo MY; Tandia A; Conway DJ
    Malar J; 2016 Feb; 15():80. PubMed ID: 26861780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulocytes: Plasmodium vivax target cells.
    Moreno-Pérez DA; Ruíz JA; Patarroyo MA
    Biol Cell; 2013 Jun; 105(6):251-60. PubMed ID: 23458497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Plasmodium vivax Biology for Control, Elimination, and Research.
    Olliaro PL; Barnwell JW; Barry A; Mendis K; Mueller I; Reeder JC; Shanks GD; Snounou G; Wongsrichanalai C
    Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):4-14. PubMed ID: 27799636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rheopathobiology of Plasmodium vivax and Other Important Primate Malaria Parasites.
    Russell BM; Cooke BM
    Trends Parasitol; 2017 Apr; 33(4):321-334. PubMed ID: 28040374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Plasmodium falciparum and Plasmodium vivax recent exposure in an area of significantly decreased transmission intensity in Central Vietnam.
    Kattenberg JH; Erhart A; Truong MH; Rovira-Vallbona E; Vu KAD; Nguyen THN; Nguyen VH; Nguyen VV; Bannister-Tyrrell M; Theisen M; Bennet A; Lover AA; Tran TD; Nguyen XX; Rosanas-Urgell A
    Malar J; 2018 Apr; 17(1):180. PubMed ID: 29703200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Epidemiology of Plasmodium vivax.
    Howes RE; Battle KE; Mendis KN; Smith DL; Cibulskis RE; Baird JK; Hay SI
    Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):15-34. PubMed ID: 27402513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticulocyte Preference and Stage Development of Plasmodium vivax Isolates.
    Lim C; Pereira L; Saliba KS; Mascarenhas A; Maki JN; Chery L; Gomes E; Rathod PK; Duraisingh MT
    J Infect Dis; 2016 Oct; 214(7):1081-4. PubMed ID: 27432121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia.
    Parobek CM; Lin JT; Saunders DL; Barnett EJ; Lon C; Lanteri CA; Balasubramanian S; Brazeau N; DeConti DK; Garba DL; Meshnick SR; Spring MD; Chuor CM; Bailey JA; Juliano JJ
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8096-E8105. PubMed ID: 27911780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control and elimination of Plasmodium vivax.
    Shanks GD
    Adv Parasitol; 2012; 80():301-41. PubMed ID: 23199491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium vivax pre-erythrocytic vaccines.
    Reyes-Sandoval A
    Parasitol Int; 2021 Oct; 84():102411. PubMed ID: 34166786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The In Vitro Invasion Inhibition Assay (IIA) for Plasmodium vivax.
    Roobsoong W
    Methods Mol Biol; 2015; 1325():187-96. PubMed ID: 26450389
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Bourgard C; Albrecht L; Kayano ACAV; Sunnerhagen P; Costa FTM
    Front Cell Infect Microbiol; 2018; 8():34. PubMed ID: 29473024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.